Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) News

Latest headlines that mention RANI, newest first · each headline opens the original publisher

RANI quote

Last price: $0.64
Day change: -5.79%
Next earnings: 2026-11-05

Quote & chart Expected move Insider trading IV rank history

RANI headlines

latest coverage

Not much coverage yet. RANI has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Investing.com 11d ago

Rani Therapeutics’ pill platform accepted into FDA program

General T3RANI

Investing.com 1mo ago

Rani Therapeutics at H.C. Wainwright: oral biologics gain traction

General T3RANI

Seeking Alpha 2mo ago

Rani Therapeutics GAAP EPS of -$0.04 beats by $0.01, revenue of $1.71M beats by $0.78M

Earnings T2RANI

Investing.com 2mo ago

Form 4 Rani Therapeutics Holdings Inc For: 21 July

General T3RANI

Investing.com 4mo ago

Rani Therapeutics raises $20 million in direct offering

General T3RANI

Seeking Alpha 4mo ago

Rani Therapeutics to raise $20M in registered direct offering

General T2RANI

Seeking Alpha 5mo ago

Rani Therapeutics CFO Sanford to depart

General T2RANI

Seeking Alpha 5mo ago

Rani Therapeutics GAAP EPS of -$0.04 in-line, revenue of $1.7M beats by $1.2M

Earnings T2RANI

RANI news alerts

Get an alert by email or push when a new headline mentions RANI.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.